riology-Mycology 2 Study Section and served as its chair for 3 years. She serves on the editorial boards of several prestigious scientific journals and has authored over 250 articles and book chapters. She has been intimately involved in the establishment of science policy and legislation related to biomedical research and public health. Dr. Cassell has received several national and international awards and an honorary degree for her research on infectious diseases.

GORDON DeFRIESE, Ph.D., is Professor of Social Medicine, Epidemiology, and Health Policy and Administration and Director of the Cecil G. Sheps Center for Health Services Research at the University of North Carolina at Chapel Hill. He received his Ph.D. from the University of Kentucky College of Medicine. Some of his research interests are in the areas of health promotion and disease prevention, medical sociology, primary health care, rural health care, cost-benefit analysis, and cost-effectiveness. He is a member of the Global Advisory Group on Health Systems Research of the World Health Organization in Geneva, past president of the Association for Health Services Research and the Foundation for Health Services Research, and a fellow of the New York Academy of Medicine. He is founder of the Partnership for Prevention, a coalition of private-sector business and industry organizations, voluntary health organizations, and state and federal public health agencies based in Washington, D.C., that have joined together to work toward the elevation of disease prevention among the nation's health policy priorities.

RENU GUPTA, M.D., is Vice President, Medical Safety and Therapeutics of Corarice. As an infectious disease specialist, Dr. Gupta is active in a number of professional societies, including the Infectious Diseases Society of America and the American Society for Microbiology, where she is a member of the committee on education. She is a frequent presenter at the Interscience Conference on Antimicrobial Agents and Chemotherapy and other major infectious disease congresses and has been published in leading infectious disease periodicals such as Journal of Virology, the Journal of Infectious Diseases, and Antimicrobial Agents and Chemotherapy. Dr. Gupta received her M.B. and Ch.B. from the University of Zambia. Subsequently, she served as Chief Resident in Pediatrics at the Albert Einstein Medical Center and as a Fellow in Infectious Diseases at the Children's Hospital of Philadelphia. She was also Postdoctoral Fellow in Microbiology at the University of Pennsylvania and the Wistar Institute of Anatomy and Biology, where she conducted research on the pathogenesis of infectious diseases. From 1989 to mid-1998, Dr. Gupta was with Bristol-Myers Squibb Company, where she directed clinical research as well as strategic planning for the Infectious Diseases and Immunology Division. For the past several years, her work has focused on a better understanding of the problem of emerging infections. Dr. Gupta currently chairs the steering committee for the SENTRY Antimicrobial Surveillance Program.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement